dalteparin has been researched along with psi 697 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedard, PW; Hawley, AE; Henke, PK; Kaila, N; Meier, TR; Myers, DD; Schaub, RG; Shaw, G; Wakefield, TW; Wrobleski, SK | 1 |
1 other study(ies) available for dalteparin and psi 697
Article | Year |
---|---|
Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.
Topics: Animals; Anticoagulants; Constriction, Pathologic; Disease Models, Animal; Enoxaparin; Fibrosis; Hydroxyquinolines; Leukocytes; Monocyte Chemoattractant Proteins; Organic Chemicals; P-Selectin; Rats; Rats, Sprague-Dawley; Selectins; Tunica Intima; Vena Cava, Inferior; Venous Thrombosis | 2006 |